drugset
drugset / Trial / NCT02992236

Effects of the NO-synthase Inhibitor VAS203 on Renal Function in Healthy Volunteers

NCT02992236 ↗

Phase 1 Completed 16 enrolled veriNOS operations GmbH Winicker Norimed GmbH · collab
RandomizedCrossoverQuadruple-blindOther

Summary

Analysis of the effect of the NO-Synthase inhibitor VAS203 (6 hours infusion of 10 mg/kg) on renal function and perfusion in 16 healthy subjects.

Timeline

Start
2015-08
Primary completion
2016-05
Completion
2016-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator RONOPTERIN Small molecule 10 mg/kg Intravenous

Indications

No indication recorded.